377 Characterization of peripheral biomarkers of GS-1423, a first in class bifunctional anti-CD73-TGFβ receptor II- trap molecule, in a phase 1 dose escalation study in patients with advanced solid tumors

• Michael Gordon,
• Anthony Tolcher,
• James Strauss,
• Rick Sorensen,
• Marianna Zavodovskaya,
• Ping Cheng Yi,
• Audrey Goddard,
• Matthew Peach,
• Kathleen Mahoney,
• Xiaoyun Yang,
• Kai-Wen Lin,
• Biao Li,
• Anna Seto,
• Tianling Chen,
• Juliane Jürgensmeier

Affiliations

Michael Gordon

4HonorHealth Cancer Care Network, Scottsdale, AZ, USA

Anthony Tolcher

6Next Onoclogy, San Antonio, TX, USA

James Strauss

2Mary Crowley Cancer Research Center, Dallas, TX, USA

Rick Sorensen

Gilead Sciences, Seattle, WA, USA

Marianna Zavodovskaya

Gilead Sciences, Seattle, WA, USA

Ping Cheng Yi

Gilead Sciences, Seattle, WA, USA

Audrey Goddard

Gilead Sciences, Seattle, WA, USA

Matthew Peach

Gilead Sciences, Seattle, WA, USA

Kathleen Mahoney

5Beth Israel Deaconess Medical Center, Boston, MA, USA

Xiaoyun Yang

6Roche, South San Francisco, CA, USA

Kai-Wen Lin

1Gilead Sciences, Woodside, CA, USA

Biao Li

1Gilead Sciences, Woodside, CA, USA

Anna Seto

1Gilead Sciences, Woodside, CA, USA

Tianling Chen

1Gilead Sciences, Woodside, CA, USA

Juliane Jürgensmeier

1Gilead Sciences, Woodside, CA, USA